Polymorphism of IL-1 receptor antagonist gene: Role in cancer

Anticancer Research

Volumn 22, Issue 6 A, 2002, Pages 3421-3424

  Sehouli, Jalid ^a   Mustea, Alexander ^a   Könsgen, Dominique ^a   Katsares, Ioanna ^a   Lichtenegger, Werner ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cancer; IL 1 receptor antagonist; Polymorphism; Review

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ALLELE; CANCER GENETICS; CANCER RISK; CARCINOGENESIS; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNOMODULATION; OVARY CANCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; STOMACH CANCER;

ALLELES; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; POLYMORPHISM, GENETIC; PROGNOSIS; SIALOGLYCOPROTEINS; STOMACH NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 0036870118     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Jeremias J, Ledger WJ and Witkin S: Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am J Obstet Gynecol 182 (2): 283-285, 2000.
2. Strauss JF: Unravelling the genetics of complex disorders of reproduction. In: Countinuto EM, Spinola P, eds: Reproductive Medicine: A Millennium Review. New-York: The Parthenon Publishing Group, 1999: pp 284-7.
3. Witkin SS, Gerber S and Ledger WJ: Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 15: 34(2): 204-9, Review 2002.
4. Arend WP: Interleukin 1 receptor antagonist: Discovery, structure and properties. Prog Growth Factor Res 2: 193-205, 1990.
5. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87:2095-2147, 1996.
6. Steinkasserer A, Spurr NK, Cox S, Jeggo P and Sim RB: The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14- q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics 13(3): 654-7, 1992.
7. Patterson D, Jones C, Hart I, Bleskan J, Berger R, Geyer D et al: The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region. Genomics 15(1): 173-6, 1993.
8. Arend WP, Malyak M, Guthridge CJ and Gabay C: Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 16: 27-55. Review 1998.
9. Unfried G, Tempfer C, Schneeberger C et al: Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 75(4): 683-7, 2001.
10. Dinarello CA and Thompson RC: Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 12: 404-410, 1991.
11. Tomimatsu S, Ichikura T and Mochizuki H: Significant correlation between expression of interleukin-1alpha and liver metastasis in gastric carcinoma. Cancer 1 91(7): 272-6, 2001.
12. Castrilli G and Tatone A: Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. Br J Cancer 75(6): 855-859, 1997.
13. L.H. Tseng, and PJ Chen: Single nucleotide polymorphisms in Intron 2 of the human IL-1 RA. Tissue Antigens 57: 318-324, 2001.
14. Van Le L, Haskill S, Jaffe GJ and Fowler WC: Expression of interleukin 1 and interleukin 1 receptor antagonist in endometrial cancer. Gynecol Oncol 42: 161-164, 1991.
15. Smith DR, Kunkel SL, Standiford TJ et al: The production of interleukin 1 receptor antagonist by human bronchogenic carcinoma. Am J Pathol 143: 794-803, 1993.
16. Oelmann, E, Kraemer A, Serve H et al: Autocrine interleukin 1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin 1. Int J Cancer 71: 1066-1076, 1997.
17. Iizuka N, Hazama S and Hirose K: Interleukin 1 receptor antagonist mRNA expression and the progression of gastric carcinoma. Cancer Lett 142: 179-184, 1999.
18. Fujiwaki R, Hata T, Miyazaki K, Kawamura T and Inada K: Elevation of serum interleukin-1 receptor antagonist levels in women with gynaecological cancers. Br J Obstet Gynaecol 104(12): 1407-1408, 1997.
19. McIntyre KW, Stepan GJ, Kolinsky KD et al: Inhibition of interleukin 1 binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti IL-1 receptor monoclonal antibody. J Exp Med 173: 931-9 1991.
20. Granowitz EV, Santos AA, Poutsiaka DD et al: Production of interleukin-1 receptor antagonist during experimental endotoxaemia. Lancet 338:1423-4 1991.
21. Tarlow JK, Blakemore AI, Lennard A et al: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-base pair tandem repeat. Hum Genet 91: 403-4 1993.
22. Rider LG, Artlett CM, Foster CB et al: Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies. Clin Exp Immunol 121: 47-52, 2000.
23. Mwantembe O, Gaillard MC, Barkhuizen M et al: Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease and in control individuals. Immunogenetics 52: 249-54, 2001.
24. Bidwell J, Keen L, Gallagher G et al: Cytokine gene polymorphism in human disease: on-line databases. Genes Immunity 1: 3-19, 1999.
25. Arnalich F, Lopez-Maderuelo D, Codoceo R et al: Interleukin-1 receptor antagonist gene polymorphism and mortality, in patients with severe sepsis. Clin Exp Immunol 127(2): 331-6, 2002.
26. Hurme M, Santtila S: IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-lbeta genes. Eur J Immunol 28(8): 2598-602, 1998.
27. Santtila S, Savinainen K and Hurme M: Presence of the IL-1RA allele 2 (IL-1 RN*2) is associated with enhanced IL-1 production in vitro. Scand J Immunol 47(3): 195-8, 1998.
28. Lynch EA, Dinarello CA and Cannon JG: Gender differences in IL-1alpha, IL-1beta, and IL-1receptor antagonist secretion from mononuclear cells and urinary excretion. J Immunol 153: 300-6, 1994.
29. Kanai T, Fukuda-Miki M, Shimoya K et al: Increased interleukin-1 and interleukin-1 receptor antagonist levels in cervical mucus in the ovulatory phase in comparison with the follicular phase. Gynecol Obstet Invest 43: 166-70, 1997.
30. Demeter J, Messer G, Ramisch S et al: Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies. Cytokines Mol Ther 2(4): 239-42, 1996.
31. Hulkkonen J, Vilpo J, Vilpo L, Koski T and Hurme M: Interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters. Haematologica 85(6): 600-6, 2000.
32. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH et al.: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (6776): 398-402, 2000.
33. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C et al.: Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121(4): 823-9, 2001.
34. Mustea A, Sehouli J, Sofroni D, Heinze T and Lichtnegger W: Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer. Anticancer Res 1B (22): 486, 2002.
35. Hulkkonen J, Vilpo J, Vilpo L, Koski T and Hurme M: Interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters. Haematologica 85(6): 600-6, 2000.
36. Dinarello C: Interleukin-1, Interleukin-1 receptors and Interleukin-1 receptor antagonist. Intern Rev Immunol 16: 457-499, 1998.
37. Garces K: Anakinra. interleukin-1 receptor antagonist therapy for rheumatoid arthritis. Issues Emerg Health Technol 16: 1-4, 2001.